Qube Research & Technologies Ltd

Position in BEAM — Beam Therapeutics Inc.

CIK 1729829 LONDON, X0

Position in BEAM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,660,928

-$19,189,093 QoQ

Shares Held

194,083

-82.1% QoQ

Ownership

0.188%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#46

of 274 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,068,185 across 169 Biotechnology names. BEAM ranks #63 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,660,928	194,083	-82.1%	Shares	Sole	2026-08-14
2026-03-31	$25,850,021	1,084,768	+171.4%	Shares	Sole	2026-05-15
2025-12-31	$11,078,547	399,659	+467.4%	Shares	Sole	2026-02-17
2025-09-30	$1,709,360	70,431	-88.1%	Shares	Sole	2025-11-14
2025-06-30	$10,100,793	593,815	+480.1%	Shares	Sole	2025-08-14
2024-06-30	$2,398,271	102,359	+4.4%	Shares	Sole	2024-08-14
2024-03-31	$3,239,737	98,055	-14.4%	Shares	Sole	2024-05-14
2023-03-31	$3,508,072	114,568	+510.3%	Shares	Sole	2023-05-15
2022-03-31	$1,075,692	18,773	+335.1%	Shares	Sole	2022-05-09
2021-09-30	$375,448	4,315	+61.3%	Shares	Sole	2021-11-12
2021-06-30	$344,299	2,675	-32.9%	Shares	Sole	2021-08-13
2021-03-31	$319,039	3,986	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.